Investigations Operations Manual: FDA Field Inspection and Investigation Policy and Procedure Concise Reference

Investigations Operations Manual: FDA Field Inspection and Investigation Policy and Procedure Concise Reference

by Mindy J. Allport-Settle
Investigations Operations Manual: FDA Field Inspection and Investigation Policy and Procedure Concise Reference

Investigations Operations Manual: FDA Field Inspection and Investigation Policy and Procedure Concise Reference

by Mindy J. Allport-Settle

eBook

$49.99 

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers

LEND ME® See Details

Overview

The IOM is the primary guidance document on FDA inspection policy and procedures for field investigators and inspectors. This extends to all individuals who perform field investigational activities in support of the Agency's public mission. Accordingly, it directs the conduct of all fundamental field investigational activities. Adherence to this manual is paramount to assure quality, consistency, and efficiency in field operations. The specific information in this manual is supplemented, not superseded, by other manuals and field guidance documents.

The IOM is recommended reading for all operations regulated by the Food and Drug Administration.

Product Details

BN ID: 2940011815898
Publisher: PharmaLogika
Publication date: 01/15/2010
Sold by: Barnes & Noble
Format: eBook
Pages: 800
File size: 3 MB

About the Author

Following in the footsteps of Gordon Allport, all of Mindy J. Allport-Settle's books are built on a foundation of psychology and sociology with a focus on improving some aspect of industry through research and education.

Her career in healthcare began when she was a teenager working as an emergency medical technician. Since then, she has joined the U.S. Navy's advanced hospital corps, worked in organ and human tissue procurement, specialized in ophthalmology, and moved on to serve as a key executive, board member, and consultant for some of the best companies in the pharmaceutical, medical device, and biotechnology industry. She has provided guidance in regulatory compliance, corporate structuring, restructuring and turnarounds, new drug submissions, research and development and product commercialization strategies, and new business development. Her experience and dedication have resulted in international recognition as the developer of the only FDA-recognized and benchmarked quality systems training and development business methodology.

Her education includes a Bachelor's degree from the University of North Carolina, an MBA in Global Management from the University of Phoenix, and completion of the corporate governance course series in audit committees, compensation committees, and board effectiveness at Harvard Business School.
From the B&N Reads Blog

Customer Reviews